1
|
Jean FA, Jouni A, Bouvard MP, Camelot G, Beggiato A, Scheid I, Gaman A, Bouquet C, Ly-Le Moal M, Houenou J, Delorme R, Leboyer M, Amestoy A. Overlap of anxiety, depression, irritability and aggressiveness in autism spectrum disorder: an exploratory study using cluster analysis. AIA 2021. [DOI: 10.1108/aia-08-2020-0048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Purpose
This study aims to explore the overlap between symptoms of depression, anxiety, irritability and aggressiveness in autism spectrum disorder (ASD), to measure specific and idiosyncratic emotional responses.
Design/methodology/approach
A total of 42 high functioning adolescents and adults, between 12 and 39 years old, meeting the diagnostic and statistical manual of mental disorders – 5 criteria for ASD were selected from the InFoR Autism cohort. Data were analyzed in an exploratory way using Hill and Smith and K-medoids cluster analysis.
Findings
The authors found an aggregation of anxiety, depression, aggressive behaviors and irritability. Cluster analysis was maximized for two groups with 17 and 25 participants, respectively. The first group was characterized by high levels of symptoms of irritability, aggressiveness, hyperactivity and intermediate levels of anxiety and depression. In the first group, participants had significantly higher levels of autistic symptoms considering the social responsiveness scale and repetitive behavior scale-revised scales (relatives’ reports) suggesting that a particular group of subjects with a high level of ASD specific symptoms may express anxiety and depression in a specific way based on externalizing behaviors in addition to the common mood and anxiety symptoms.
Research limitations/implications
Improved understanding of the aggregation of externalized symptoms with symptoms of anxiety and mood disorders in ASD should lead to a better understanding of the underlying mechanisms related to emotion dysregulation in ASD.
Practical implications
Improved knowledge of the symptoms could lead to enhanced detection of psychiatric comorbidities in ASD.
Originality/value
The study was based on a transdiagnostic approach of psychiatric symptoms in individuals with ASD. Aggregation and clustering analysis was used to explore naive patterns of these psychiatric symptoms.
Collapse
|
2
|
Baltazar M, Geoffray MM, Chatham C, Bouvard M, Martinez Teruel A, Monnet D, Scheid I, Murzi E, Couffin-Cadiergues S, Umbricht D, Murtagh L, Delorme R, Ly Le-Moal M, Leboyer M, Amestoy A. "Reading the Mind in the Eyes" in Autistic Adults is Modulated by Valence and Difficulty: An InFoR Study. Autism Res 2020; 14:380-388. [PMID: 32929870 PMCID: PMC7891586 DOI: 10.1002/aur.2390] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Revised: 07/08/2020] [Accepted: 08/22/2020] [Indexed: 12/19/2022]
Abstract
Autism spectrum disorders (ASD) are heterogeneous and complex neurodevelopmental conditions that urgently need reliable and sensitive measures to inform diagnosis properly. The Reading the Mind in the Eyes Task (or Eyes Test from now on) is widely used for this purpose. A recent study showed that subcategories of items of the children version of the Eyes Test could be especially discriminative to distinguish ASD and control children. Here, we analyzed the performance on the Eyes Test of 30 high functioning (IQ > 70) adults with ASD and 29 controls from the InFoR cohort multicentric study, using a Generalized Linear Mixed Model. We found that valence and difficulty modulate the performance on the Eyes Test, with easy and positive items being the most discriminative to distinguish ASD and controls. In particular, we suggest this result might be actionable to discriminate ASD patients from controls in subgroups where their overall scores show less difference with controls. We propose for future research the computation of two additional indexes when using the Eyes Test: the first focusing on the easy and positive items (applying a threshold of 70% of correct responses for these items, above which people are at very low risk of having ASD) and the second focusing on the performance gain from difficult to easy items (with a progression of less than 15% showing high risk of having ASD). Our findings open the possibility for a major change in how the Eyes Test is used to inform diagnosis in ASD. Lay Summary The Eyes Test is used worldwide to inform autism spectrum disorders (ASD) diagnosis. We show here that ASD and neurotypical adults show the most difference in performance on subgroups of items: ASD adults do not improve as expected when comparing easy and difficult items, and they do not show an improvement for items displaying a positive feeling. We advise clinicians to focus on these comparisons to increase the property of the test to distinguish people with ASD from neurotypical adults.
Collapse
Affiliation(s)
- Matias Baltazar
- Centre d'Evaluation et Diagnostic de l'Autisme (CEDA), Centre Hospitalier Le Vinatier, Bron, France
| | - Marie-Maude Geoffray
- Centre d'Evaluation et Diagnostic de l'Autisme (CEDA), Centre Hospitalier Le Vinatier, Bron, France
| | | | - Manuel Bouvard
- Université de Bordeaux, Bordeaux, France.,Pôle Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Centre Hospitalier Charles-Perrens, Bordeaux, France.,Centre National Pour La Recherche Scientifique, INCIA UMR 5287, Bordeaux, France.,Fondation FondaMental, Créteil, France
| | - Axelle Martinez Teruel
- Fondation FondaMental, Créteil, France.,UNIACT, NeuroSpin, CEA, Université Paris-Saclay, Paris, France
| | - David Monnet
- Centre Hospitalier de Versailles CHV, Hôpital Mignot, Pôle de Psychiatrie Adulte et Infanto-Juvénile, Centre Expert TSAsdi, Le Chesnay, France
| | | | | | - Sandrine Couffin-Cadiergues
- INSERM, U955, Institut Mondor de Recherches Biomédicales, IMRB, Laboratoire de Neuro-Psychiatrie translationnelle, Créteil, France
| | - Daniel Umbricht
- Roche Innovation Center, F-Hoffmann La Roche Ldt, Basel, Switzerland
| | - Lorraine Murtagh
- Roche Innovation Center, F-Hoffmann La Roche Ldt, Basel, Switzerland
| | - Richard Delorme
- Fondation FondaMental, Créteil, France.,Institut Pasteur, Paris, France.,Psychiatry and Addictology Department, Université Paris Est Créteil, AP-HP, DMU ADAPT, Mondor University Hospital, Créteil, France
| | | | - Marion Leboyer
- Fondation FondaMental, Créteil, France.,INSERM, U955, Institut Mondor de Recherches Biomédicales, IMRB, Laboratoire de Neuro-Psychiatrie translationnelle, Créteil, France
| | - Anouck Amestoy
- Université de Bordeaux, Bordeaux, France.,Pôle Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Centre Hospitalier Charles-Perrens, Bordeaux, France.,Centre National Pour La Recherche Scientifique, INCIA UMR 5287, Bordeaux, France.,Fondation FondaMental, Créteil, France
| |
Collapse
|
3
|
d'Albis MA, Guevara P, Guevara M, Laidi C, Boisgontier J, Sarrazin S, Duclap D, Delorme R, Bolognani F, Czech C, Bouquet C, Ly-Le Moal M, Holiga S, Amestoy A, Scheid I, Gaman A, Leboyer M, Poupon C, Mangin JF, Houenou J. Local structural connectivity is associated with social cognition in autism spectrum disorder. Brain 2019; 141:3472-3481. [PMID: 30423029 DOI: 10.1093/brain/awy275] [Citation(s) in RCA: 33] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2018] [Accepted: 09/12/2018] [Indexed: 12/13/2022] Open
Abstract
The current theory implying local, short-range overconnectivity in autism spectrum disorder, contrasting with long-range underconnectivity, is based on heterogeneous results, on limited data involving functional connectivity studies, on heterogeneous paediatric populations and non-specific methodologies. In this work, we studied short-distance structural connectivity in a homogeneous population of males with high-functioning autism spectrum disorder and used a novel methodology specifically suited for assessing U-shaped short-distance tracts, including a recently developed tractography-based atlas of the superficial white matter fibres. We acquired diffusion-weighted MRI for 58 males (27 subjects with high-functioning autism spectrum disorder and 31 control subjects) and extracted the mean generalized fractional anisotropy of 63 short-distance tracts. Neuropsychological evaluation included Wechsler Adult Intelligence Scale IV (WAIS-IV), Communication Checklist-Adult, Empathy Quotient, Social Responsiveness Scale and Behaviour Rating Inventory of Executive Function-Adult (BRIEF-A). In contradiction with the models of short-range over-connectivity in autism spectrum disorder, we found that patients with autism spectrum disorder had a significantly decreased anatomical connectivity in a component comprising 13 short tracts compared to controls. Specific short-tract atypicalities in temporal lobe and insula were significantly associated with clinical manifestations of autism spectrum disorder such as social awareness, language structure, pragmatic skills and empathy, emphasizing their importance in social dysfunction. Short-range decreased anatomical connectivity may thus be an important substrate of social deficits in autism spectrum disorder, in contrast with current models.
Collapse
Affiliation(s)
- Marc-Antoine d'Albis
- UNIACT, Psychiatry Team, Neurospin, Atomic Energy Commission, Gif-Sur-Yvette, France.,INSERM, U955, Translational Psychiatry Team, Créteil, France.,Fondation Fondamental, Créteil, France.,Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Psychiatry, Mondor University Hospital, DHU PePsy, Créteil, France
| | - Pamela Guevara
- Faculty of Engineering, Universidad de Concepción, Concepción, Chile
| | - Miguel Guevara
- Faculty of Engineering, Universidad de Concepción, Concepción, Chile.,Neurospin, CEA, Paris Saclay University, Gif-sur-Yvette, France
| | - Charles Laidi
- UNIACT, Psychiatry Team, Neurospin, Atomic Energy Commission, Gif-Sur-Yvette, France.,INSERM, U955, Translational Psychiatry Team, Créteil, France.,Fondation Fondamental, Créteil, France.,Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Psychiatry, Mondor University Hospital, DHU PePsy, Créteil, France
| | - Jennifer Boisgontier
- UNIACT, Psychiatry Team, Neurospin, Atomic Energy Commission, Gif-Sur-Yvette, France.,INSERM, U955, Translational Psychiatry Team, Créteil, France.,Fondation Fondamental, Créteil, France
| | - Samuel Sarrazin
- UNIACT, Psychiatry Team, Neurospin, Atomic Energy Commission, Gif-Sur-Yvette, France.,INSERM, U955, Translational Psychiatry Team, Créteil, France.,Fondation Fondamental, Créteil, France.,Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Psychiatry, Mondor University Hospital, DHU PePsy, Créteil, France
| | - Delphine Duclap
- Neurospin, CEA, Paris Saclay University, Gif-sur-Yvette, France
| | - Richard Delorme
- Fondation Fondamental, Créteil, France.,Service de psychiatrie de l'enfant et de l'adolescent, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Robert Debré, Paris, France.,Institut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France
| | - Federico Bolognani
- Neuroscience, Ophtalmology, and Rare Disease (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F.Hoffman-La Roche Ltd. Basel, Switzerland
| | - Christian Czech
- Neuroscience, Ophtalmology, and Rare Disease (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F.Hoffman-La Roche Ltd. Basel, Switzerland
| | - Céline Bouquet
- Neuroscience, Ophtalmology, and Rare Disease (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F.Hoffman-La Roche Ltd. Basel, Switzerland
| | | | - Stefan Holiga
- Neuroscience, Ophtalmology, and Rare Disease (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F.Hoffman-La Roche Ltd. Basel, Switzerland
| | - Anouck Amestoy
- Charles Perrens Hospital, Autism Expert Center, Bordeaux, France
| | - Isabelle Scheid
- INSERM, U955, Translational Psychiatry Team, Créteil, France.,Fondation Fondamental, Créteil, France.,Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Psychiatry, Mondor University Hospital, DHU PePsy, Créteil, France
| | - Alexandru Gaman
- INSERM, U955, Translational Psychiatry Team, Créteil, France.,Fondation Fondamental, Créteil, France.,Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Psychiatry, Mondor University Hospital, DHU PePsy, Créteil, France
| | - Marion Leboyer
- INSERM, U955, Translational Psychiatry Team, Créteil, France.,Fondation Fondamental, Créteil, France.,Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Psychiatry, Mondor University Hospital, DHU PePsy, Créteil, France.,Faculté de Médecine, Université Paris Est Créteil, Créteil, France
| | - Cyril Poupon
- Neurospin, CEA, Paris Saclay University, Gif-sur-Yvette, France
| | | | - Josselin Houenou
- UNIACT, Psychiatry Team, Neurospin, Atomic Energy Commission, Gif-Sur-Yvette, France.,INSERM, U955, Translational Psychiatry Team, Créteil, France.,Fondation Fondamental, Créteil, France.,Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Psychiatry, Mondor University Hospital, DHU PePsy, Créteil, France.,Faculté de Médecine, Université Paris Est Créteil, Créteil, France
| |
Collapse
|
4
|
Bennabi M, Tarantino N, Gaman A, Scheid I, Krishnamoorthy R, Debré P, Bouleau A, Caralp M, Gueguen S, Le-Moal ML, Bouvard M, Amestoy A, Delorme R, Leboyer M, Tamouza R, Vieillard V. Persistence of dysfunctional natural killer cells in adults with high-functioning autism spectrum disorders: stigma/consequence of unresolved early infectious events? Mol Autism 2019; 10:22. [PMID: 31123562 PMCID: PMC6521549 DOI: 10.1186/s13229-019-0269-1] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2019] [Accepted: 03/18/2019] [Indexed: 12/27/2022] Open
Abstract
Background Autism spectrum disorders (ASD) are characterized by abnormal neurodevelopment, genetic, and environmental risk factors, as well as immune dysfunctions. Several lines of evidence suggest alterations in innate immune responses in children with ASD. To address this question in adults with high-functioning ASD (hf-ASD), we sought to investigate the role of natural killer (NK) cells in the persistence of ASD. Methods NK cells from 35 adults with hf-ASD were compared to that of 35 healthy controls (HC), selected for the absence of any immune dysfunctions, at different time-points, and over a 2-year follow-up period for four patients. The phenotype and polyfunctional capacities of NK cells were explored according to infectious stigma and clinical parameters (IQ, social, and communication scores). Results As compared to HC, NK cells from patients with hf-ASD showed a high level of cell activation (p < 0.0001), spontaneous degranulation (p < 0.0001), and interferon-gamma production (p = 0.0004), whereas they were exhausted after in vitro stimulations (p = 0.0006). These data yielded a specific HLA-DR+KIR2DL1+NKG2C+ NK-cell signature. Significant overexpression of NKG2C in hf-ASD patients (p = 0.0005), indicative of viral infections, was inversely correlated with the NKp46 receptor level (r = − 0.67; p < 0.0001), regardless of the IgG status of tested pathogens. Multivariate linear regression analysis also revealed that expression of the late-activating HLA-DR marker was both associated with structural language (r = 0.48; p = 0.007) and social awareness (r = 0.60; p = 0.0007) scores in adult patients with hf-ASD, while KIR2DL1 expression correlated with IQ scores (p = 0.0083). Conclusions This study demonstrates that adults with hf-ASD have specific NK-cell profile. Presence of NKG2C overexpression together with high-level activation of NK cells suggest an association with underlying pathogens, a hypothesis warranting further exploration in future studies. Electronic supplementary material The online version of this article (10.1186/s13229-019-0269-1) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Meriem Bennabi
- 1INSERM, U1160, Hôpital Saint Louis, Paris, France.,2Fondation FondaMental, Créteil, France.,4DHU PePSY, Department of psychiatry, Mondor Hospital, Université Paris Est Créteil, INSERM, U955, Psychiatrie Translationnelle, Créteil, France
| | - Nadine Tarantino
- 3Sorbonne Université, UPMC, INSERM U1135, CNRS ERL8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| | - Alexandru Gaman
- 2Fondation FondaMental, Créteil, France.,4DHU PePSY, Department of psychiatry, Mondor Hospital, Université Paris Est Créteil, INSERM, U955, Psychiatrie Translationnelle, Créteil, France
| | - Isabelle Scheid
- 2Fondation FondaMental, Créteil, France.,4DHU PePSY, Department of psychiatry, Mondor Hospital, Université Paris Est Créteil, INSERM, U955, Psychiatrie Translationnelle, Créteil, France
| | | | - Patrice Debré
- 3Sorbonne Université, UPMC, INSERM U1135, CNRS ERL8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| | - Arthur Bouleau
- 4DHU PePSY, Department of psychiatry, Mondor Hospital, Université Paris Est Créteil, INSERM, U955, Psychiatrie Translationnelle, Créteil, France
| | - Mireille Caralp
- 5Inserm Transfer, Paris, France.,6French Institute of Health and Medical Research, Paris, France
| | - Sonia Gueguen
- 5Inserm Transfer, Paris, France.,6French Institute of Health and Medical Research, Paris, France
| | | | - Manuel Bouvard
- 2Fondation FondaMental, Créteil, France.,8Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, Université de Bordeaux, Bordeaux, France
| | - Anouck Amestoy
- 2Fondation FondaMental, Créteil, France.,8Institut de Neurosciences Cognitives et Intégratives d'Aquitaine, Université de Bordeaux, Bordeaux, France
| | - Richard Delorme
- 2Fondation FondaMental, Créteil, France.,DHU Protect, Service de Psychiatrie de l'Enfant et de l'Adolescent, Hôpital Robert Debré, Département de Génétique Humaine et Fonctions Cognitives, Institut Pasteur, Paris, France
| | - Marion Leboyer
- 2Fondation FondaMental, Créteil, France.,4DHU PePSY, Department of psychiatry, Mondor Hospital, Université Paris Est Créteil, INSERM, U955, Psychiatrie Translationnelle, Créteil, France
| | - Ryad Tamouza
- 1INSERM, U1160, Hôpital Saint Louis, Paris, France.,2Fondation FondaMental, Créteil, France.,4DHU PePSY, Department of psychiatry, Mondor Hospital, Université Paris Est Créteil, INSERM, U955, Psychiatrie Translationnelle, Créteil, France
| | - Vincent Vieillard
- 3Sorbonne Université, UPMC, INSERM U1135, CNRS ERL8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| |
Collapse
|
5
|
Holiga Š, Hipp JF, Chatham CH, Garces P, Spooren W, D’Ardhuy XL, Bertolino A, Bouquet C, Buitelaar JK, Bours C, Rausch A, Oldehinkel M, Bouvard M, Amestoy A, Caralp M, Gueguen S, Ly-Le Moal M, Houenou J, Beckmann CF, Loth E, Murphy D, Charman T, Tillmann J, Laidi C, Delorme R, Beggiato A, Gaman A, Scheid I, Leboyer M, d’Albis MA, Sevigny J, Czech C, Bolognani F, Honey GD, Dukart J. Patients with autism spectrum disorders display reproducible functional connectivity alterations. Sci Transl Med 2019. [DOI: 10.1126/scitranslmed.aat9223 order by 39635--] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Affiliation(s)
- Štefan Holiga
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
| | - Joerg F. Hipp
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
| | - Christopher H. Chatham
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
| | - Pilar Garces
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
| | - Will Spooren
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
| | - Xavier Liogier D’Ardhuy
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
| | - Alessandro Bertolino
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
- Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari ‘Aldo Moro’, 70121 Bari, Italy
| | - Céline Bouquet
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
| | - Jan K. Buitelaar
- Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University Nijmegen Medical center, Nijmegen 6525 EN, Netherlands
| | - Carsten Bours
- Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University Nijmegen Medical center, Nijmegen 6525 EN, Netherlands
| | - Annika Rausch
- Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University Nijmegen Medical center, Nijmegen 6525 EN, Netherlands
| | - Marianne Oldehinkel
- Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University Nijmegen Medical center, Nijmegen 6525 EN, Netherlands
- Brain & Mental Health Laboratory, Monash Institute of Cognitive and Clinical Neurosciences and School of Psychological Sciences, Monash University, Clayton, VIC 3800, Australia
| | - Manuel Bouvard
- Pôle Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Hôpital Charles Perrens Bordeaux, 33076 Bordeaux, France
| | - Anouck Amestoy
- Pôle Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Hôpital Charles Perrens Bordeaux, 33076 Bordeaux, France
| | - Mireille Caralp
- INSERM, National Biobank Infrastructure, 75013 Paris, France
| | - Sonia Gueguen
- INSERM, Clinical Research Department, 75014 Paris, France
| | | | - Josselin Houenou
- Hôpitaux Universitaires Mondor, DHU PePSY, Pôle de psychiatrie, Faculté de Médecine, Université Paris Est, INSERM U955, IMRB, Equipe 15, Psychiatrie Translationnelle, Fondation FondaMental, 94000 Créteil, France
- NeuroSpin, UNIACT Lab, Psychiatry Team, CEA Saclay, 91191 Gif-Sur-Yvette, France
| | - Christian F. Beckmann
- Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University Nijmegen Medical center, Nijmegen 6525 EN, Netherlands
| | - Eva Loth
- Institute of Psychiatry, Psychology & Neuroscience, King’s College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
| | - Declan Murphy
- Institute of Psychiatry, Psychology & Neuroscience, King’s College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
| | - Tony Charman
- Institute of Psychiatry, Psychology & Neuroscience, King’s College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
| | - Julian Tillmann
- Institute of Psychiatry, Psychology & Neuroscience, King’s College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK
- Department of Applied Psychology: Health, Development, Enhancement, and Intervention, University of Vienna, 1010 Vienna, Austria
| | - Charles Laidi
- Hôpitaux Universitaires Mondor, DHU PePSY, Pôle de psychiatrie, Faculté de Médecine, Université Paris Est, INSERM U955, IMRB, Equipe 15, Psychiatrie Translationnelle, Fondation FondaMental, 94000 Créteil, France
| | - Richard Delorme
- APHP, Robert Debré Hospital, Child and Adolescent Psychiatry Department, Paris, France
- Pasteur Institute, 75019 Paris, France
| | - Anita Beggiato
- APHP, Robert Debré Hospital, Child and Adolescent Psychiatry Department, Paris, France
- Pasteur Institute, 75019 Paris, France
| | - Alexandru Gaman
- Hôpitaux Universitaires Mondor, DHU PePSY, Pôle de psychiatrie, Faculté de Médecine, Université Paris Est, INSERM U955, IMRB, Equipe 15, Psychiatrie Translationnelle, Fondation FondaMental, 94000 Créteil, France
| | - Isabelle Scheid
- Hôpitaux Universitaires Mondor, DHU PePSY, Pôle de psychiatrie, Faculté de Médecine, Université Paris Est, INSERM U955, IMRB, Equipe 15, Psychiatrie Translationnelle, Fondation FondaMental, 94000 Créteil, France
| | - Marion Leboyer
- Hôpitaux Universitaires Mondor, DHU PePSY, Pôle de psychiatrie, Faculté de Médecine, Université Paris Est, INSERM U955, IMRB, Equipe 15, Psychiatrie Translationnelle, Fondation FondaMental, 94000 Créteil, France
| | - Marc-Antoine d’Albis
- Hôpitaux Universitaires Mondor, DHU PePSY, Pôle de psychiatrie, Faculté de Médecine, Université Paris Est, INSERM U955, IMRB, Equipe 15, Psychiatrie Translationnelle, Fondation FondaMental, 94000 Créteil, France
- NeuroSpin, UNIACT Lab, Psychiatry Team, CEA Saclay, 91191 Gif-Sur-Yvette, France
| | - Jeff Sevigny
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
| | - Christian Czech
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
| | - Federico Bolognani
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
- Therachon AG, Aeschenvorstadt 36, 4051 Basel, Switzerland
| | - Garry D. Honey
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
| | - Juergen Dukart
- Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann–La Roche Ltd., Grenzacherstrasse 124, 4070 Basel, Switzerland
- Institute of Neuroscience and Medicine, Brain & Behaviour (INM-7), Research Centre Jülich, 52428 Jülich, Germany
- Institute of Systems Neuroscience, Medical Faculty, Heinrich Heine University Düsseldorf, 40223 Düsseldorf, Germany
| |
Collapse
|
6
|
Holiga Š, Hipp JF, Chatham CH, Garces P, Spooren W, D’Ardhuy XL, Bertolino A, Bouquet C, Buitelaar JK, Bours C, Rausch A, Oldehinkel M, Bouvard M, Amestoy A, Caralp M, Gueguen S, Ly-Le Moal M, Houenou J, Beckmann CF, Loth E, Murphy D, Charman T, Tillmann J, Laidi C, Delorme R, Beggiato A, Gaman A, Scheid I, Leboyer M, d’Albis MA, Sevigny J, Czech C, Bolognani F, Honey GD, Dukart J. Patients with autism spectrum disorders display reproducible functional connectivity alterations. Sci Transl Med 2019; 11:11/481/eaat9223. [DOI: 10.1126/scitranslmed.aat9223] [Citation(s) in RCA: 80] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2018] [Revised: 11/22/2018] [Accepted: 02/05/2019] [Indexed: 01/16/2023]
Abstract
Despite the high clinical burden, little is known about pathophysiology underlying autism spectrum disorder (ASD). Recent resting-state functional magnetic resonance imaging (rs-fMRI) studies have found atypical synchronization of brain activity in ASD. However, no consensus has been reached on the nature and clinical relevance of these alterations. Here, we addressed these questions in four large ASD cohorts. Using rs-fMRI, we identified functional connectivity alterations associated with ASD. We tested for associations of these imaging phenotypes with clinical and demographic factors such as age, sex, medication status, and clinical symptom severity. Our results showed reproducible patterns of ASD-associated functional hyper- and hypoconnectivity. Hypoconnectivity was primarily restricted to sensory-motor regions, whereas hyperconnectivity hubs were predominately located in prefrontal and parietal cortices. Shifts in cortico-cortical between-network connectivity from outside to within the identified regions were shown to be a key driver of these abnormalities. This reproducible pathophysiological phenotype was partially associated with core ASD symptoms related to communication and daily living skills and was not affected by age, sex, or medication status. Although the large effect sizes in standardized cohorts are encouraging with respect to potential application as a treatment and for patient stratification, the moderate link to clinical symptoms and the large overlap with healthy controls currently limit the usability of identified alterations as diagnostic or efficacy readout.
Collapse
|
7
|
Bennabi M, Gaman A, Delorme R, Boukouaci W, Manier C, Scheid I, Si Mohammed N, Bengoufa D, Charron D, Krishnamoorthy R, Leboyer M, Tamouza R. HLA-class II haplotypes and Autism Spectrum Disorders. Sci Rep 2018; 8:7639. [PMID: 29769579 PMCID: PMC5955937 DOI: 10.1038/s41598-018-25974-9] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2018] [Accepted: 04/26/2018] [Indexed: 02/06/2023] Open
Abstract
Infections and autoimmunity are associated with autism spectrum disorders (ASD), with both strongly influenced by the genetic regulation of the human leukocyte antigen (HLA) system. The relationship between ASD and the HLA genetic diversity requires further investigation. Using a case control design, the distribution of HLA class II-DRB1 and DQB1 alleles, genotypes and haplotypes were investigated in ASD patients, versus healthy controls (HC). ASD patients meeting DSM-IV TR criteria and HC (474 and 350 respectively) were genotyped at medium resolution using a Luminex-based SSO technology. Comparisons of genotypes, allele frequencies associated with a haplotype analysis were performed. Results indicate: (i) the HLA-DRB1 *11-DQB1*07 haplotype was more prevalent in ASD patients, versus HC (Pc = 0.001), partially replicating previous data and possibly linking to gastro-intestinal (GI)-related pro-inflammatory processes, given that this haplotype associates with pediatric celiac disorders; (ii) the HLA-DRB1 *17-DQB1*02 haplotype was higher in HC, versus ASD patients (Pc = 0.002), indicating that this is a protective haplotype. Using the Autism Diagnostic Interview to assess clinical dimensions, higher scores on social (Pc = 0.006) and non-verbal functioning (Pc = 0.004) associated with the DRB1 *11 DQB1*07 haplotype. Our results support HLA involvement in ASD, with possible relevance to GI and gut-brain axis dysregulation.
Collapse
Affiliation(s)
- Meriem Bennabi
- INSERM, U1160, Hôpital Saint Louis, Paris, France.,INSERM, U955, Psychiatrie Translationnelle, Créteil, France.,Fondation FondaMental, Créteil, France
| | - Alexandru Gaman
- INSERM, U955, Psychiatrie Translationnelle, Créteil, France.,Fondation FondaMental, Créteil, France
| | - Richard Delorme
- Fondation FondaMental, Créteil, France.,DHU Protect, AP-HP, Service de psychiatrie de l'enfant et de l'adolescent, Hôpital Robert Debré, Paris, France.,Département de génétique humaine et fonctions cognitives, Institut Pasteur, Paris, France.,Université Paris Diderot, Sorbonne Paris-Cité, Paris, France
| | | | | | - Isabelle Scheid
- INSERM, U955, Psychiatrie Translationnelle, Créteil, France.,Fondation FondaMental, Créteil, France
| | | | - Djaouida Bengoufa
- Laboratoire Jean Dausset and LabEx Transplantex, Hôpital Saint Louis, Paris, France
| | - Dominique Charron
- INSERM, U1160, Hôpital Saint Louis, Paris, France.,Université Paris Diderot, Sorbonne Paris-Cité, Paris, France.,Laboratoire Jean Dausset and LabEx Transplantex, Hôpital Saint Louis, Paris, France
| | - Rajagopal Krishnamoorthy
- INSERM, U955, Psychiatrie Translationnelle, Créteil, France.,Fondation FondaMental, Créteil, France
| | - Marion Leboyer
- INSERM, U955, Psychiatrie Translationnelle, Créteil, France.,Fondation FondaMental, Créteil, France.,DHU PePSY, AP-HP, Pôle de Psychiatrie, Hôpitaux Universitaires Henri Mondor, Créteil, France.,Université Paris-Est-Créteil, Faculté de médecine, Créteil, France
| | - Ryad Tamouza
- INSERM, U1160, Hôpital Saint Louis, Paris, France. .,INSERM, U955, Psychiatrie Translationnelle, Créteil, France. .,Fondation FondaMental, Créteil, France. .,Université Paris Diderot, Sorbonne Paris-Cité, Paris, France. .,Laboratoire Jean Dausset and LabEx Transplantex, Hôpital Saint Louis, Paris, France. .,DHU PePSY, AP-HP, Pôle de Psychiatrie, Hôpitaux Universitaires Henri Mondor, Créteil, France.
| |
Collapse
|
8
|
Gouleme N, Scheid I, Peyre H, Seassau M, Maruani A, Clarke J, Delorme R, Bucci MP. Postural Control and Emotion in Children with Autism Spectrum Disorders. Transl Neurosci 2017; 8:158-166. [PMID: 29177103 PMCID: PMC5700205 DOI: 10.1515/tnsci-2017-0022] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2017] [Accepted: 10/25/2017] [Indexed: 01/22/2023] Open
Abstract
Autism Spectrum Disorders subjects (ASD) are well known to have deficits in social interaction. We recorded simultaneously eye movements and postural sway during exploration of emotional faces in children with ASD and typically developing children (TD). We analyzed several postural and ocular parameters. The results showed that all postural parameters were significantly greater in children with ASD; ASD made significantly fewer saccades and had shorter fixation time than TD, particularly in the eyes, and especially for unpleasant emotions. These results suggest that poor postural control of ASD and their impaired visual strategies could be due to a lack of interest in social cognition, causing a delay in the development of the cortical areas, and thus could have an effect on their postural control.
Collapse
Affiliation(s)
- Nathalie Gouleme
- UMR 1141 Inserm - Université Paris Diderot., Robert Debré Hospital, 48 Boulevard Sérurier, 75019, Paris, France
| | - Isabelle Scheid
- Child and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.,High Functioning Autism Expert Centre, Fondamental Foundation, Paris, France
| | - Hugo Peyre
- Child and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.,High Functioning Autism Expert Centre, Fondamental Foundation, Paris, France
| | - Magali Seassau
- e(ye)BRAIN, 1 bis rue Jean le Galleu, 94200, Ivry-sur-Seine, France
| | - Anna Maruani
- Child and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.,High Functioning Autism Expert Centre, Fondamental Foundation, Paris, France
| | - Julia Clarke
- Child and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.,High Functioning Autism Expert Centre, Fondamental Foundation, Paris, France
| | - Richard Delorme
- Child and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.,High Functioning Autism Expert Centre, Fondamental Foundation, Paris, France
| | - Maria Pia Bucci
- UMR 1141 Inserm - Université Paris Diderot., Robert Debré Hospital, 48 Boulevard Sérurier, 75019, Paris, France
| |
Collapse
|
9
|
Hotier S, Leroy F, Boisgontier J, Laidi C, Mangin JF, Delorme R, Bolognani F, Czech C, Bouquet C, Toledano E, Bouvard M, Petit J, Mishchenko M, d'Albis MA, Gras D, Gaman A, Scheid I, Leboyer M, Zalla T, Houenou J. Social cognition in autism is associated with the neurodevelopment of the posterior superior temporal sulcus. Acta Psychiatr Scand 2017; 136:517-525. [PMID: 28940401 DOI: 10.1111/acps.12814] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 08/29/2017] [Indexed: 12/23/2022]
Abstract
OBJECTIVE The posterior superior temporal sulcus (pSTS) plays a critical role in the 'social brain'. Its neurodevelopment and relationship with the social impairment in autism spectrum disorders (ASD) are not well understood. We explored the relationship between social cognition and the neurodevelopment of the pSTS in ASD. METHOD We included 44 adults with high-functioning ASD and 36 controls. We assessed their performances on the 'Reading the mind in the eyes' test (for 34 of 44 subjects with ASD and 30 of 36 controls), their fixation time on the eyes with eye tracking (for 35 of 44 subjects with ASD and 30 of 36 controls) and the morphology of the caudal branches of the pSTS (length and depth), markers of the neurodevelopment, with structural MRI. RESULTS The right anterior caudal ramus of the pSTS was significantly longer in patients with ASD compared with controls (52.6 mm vs. 38.3 mm; P = 1.4 × 10-3 ; Cohen's d = 0.76). Its length negatively correlated with fixation time on the eyes (P = 0.03) in the ASD group and with the 'Reading the mind in the eyes' test scores in both groups (P = 0.03). CONCLUSION Our findings suggest that the neurodevelopment of the pSTS is related to the ASD social impairments.
Collapse
Affiliation(s)
- S Hotier
- UNIACT, Psychiatry Team, Neurospin Neuroimaging Platform, CEA Saclay, Gif-Sur-Yvette, France
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- Psychiatry Department, Charles Nicolle University Hospital, Rouen, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
- Faculty of Medicine, Paris East University, Créteil, France
| | - F Leroy
- INSERM, U992, UNICOG, NeuroSpin Neuroimaging Platform, University Paris Saclay, CEA Saclay, Gif-Sur-Yvette, France
| | - J Boisgontier
- UNIACT, Psychiatry Team, Neurospin Neuroimaging Platform, CEA Saclay, Gif-Sur-Yvette, France
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
| | - C Laidi
- UNIACT, Psychiatry Team, Neurospin Neuroimaging Platform, CEA Saclay, Gif-Sur-Yvette, France
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
| | - J-F Mangin
- UNATI, Neurospin Neuroimaging Platform, CEA Saclay, Gif-Sur-Yvette, France
| | - R Delorme
- Fondation Fondamental, Créteil, France
- Child and Adolescent Psychiatry Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Robert Debré Hospital, Paris, France
- Institut Pasteur, Human Genetics and Cognitive Functions Unit, Paris, France
| | - F Bolognani
- Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | - C Czech
- Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | - C Bouquet
- Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | - E Toledano
- Institut Roche, Roche Pharmaceuticals, Boulogne-Billancourt, France
| | - M Bouvard
- Fondation Fondamental, Créteil, France
- Children and Adolescent Psychiatry Department, Bordeaux University Hospital, Bordeaux, France
| | - J Petit
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
| | - M Mishchenko
- Jean Nicod Institute, Centre National de la Recherche Scientifique, Ecole Normale Supeérieure, PSL, Research University, Paris, France
- Laboratory of Psychopathology and Health Processes (EA 4057), Paris Descartes University, Sorbonne Paris Cité, France
| | - M-A d'Albis
- UNIACT, Psychiatry Team, Neurospin Neuroimaging Platform, CEA Saclay, Gif-Sur-Yvette, France
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
| | - D Gras
- Fondation Fondamental, Créteil, France
- Jean Nicod Institute, Centre National de la Recherche Scientifique, Ecole Normale Supeérieure, PSL, Research University, Paris, France
- Laboratoire de Linguistique Formelle, CNRS, Paris Diderot University, Paris, France
| | - A Gaman
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
| | - I Scheid
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
- Child and Adolescent Psychiatry Department, Assistance Publique-Hôpitaux de Paris (AP-HP), Robert Debré Hospital, Paris, France
| | - M Leboyer
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
- Faculty of Medicine, Paris East University, Créteil, France
| | - T Zalla
- Fondation Fondamental, Créteil, France
- Jean Nicod Institute, Centre National de la Recherche Scientifique, Ecole Normale Supeérieure, PSL, Research University, Paris, France
| | - J Houenou
- UNIACT, Psychiatry Team, Neurospin Neuroimaging Platform, CEA Saclay, Gif-Sur-Yvette, France
- INSERM U955, Mondor Institute for Biomedical Research, Team 15, Translational Psychiatry, Créteil, France
- Fondation Fondamental, Créteil, France
- DHU PePSY, Department of Psychiatry, Assistance Publique-Hôpitaux de Paris (AP-HP), Mondor University Hospitals, Créteil, France
- Faculty of Medicine, Paris East University, Créteil, France
| |
Collapse
|
10
|
Gréa H, Scheid I, Gaman A, Rogemond V, Gillet S, Honnorat J, Bolognani F, Czech C, Bouquet C, Toledano E, Bouvard M, Delorme R, Groc L, Leboyer M. Clinical and autoimmune features of a patient with autism spectrum disorder seropositive for anti-NMDA-receptor autoantibody. Dialogues Clin Neurosci 2017. [PMID: 28566948 PMCID: PMC5442365 DOI: 10.31887/dcns.2017.19.1/mleboyer] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by dysfunctions in social interactions resulting from a complex interplay between immunogenetic and environmental risk factors. Autoimmunity has been proposed as a major etiological component of ASD. Whether specific autoantibodies directed against brain targets are involved in ASD remains an open question. Here, we identified within a cohort an ASD patient with multiple circulating autoantibodies, including the well-characterized one against glutamate NMDA receptor (NMDAR-Ab). The patient exhibited alexithymia and previously suffered from two major depressive episodes without psychotic symptoms. Using a single molecule-based imaging approach, we demonstrate that neither NMDAR-Ab type G immunoglobulin purified from the ASD patient serum, nor that from a seropositive healthy subject, disorganize membrane NMDAR complexes at synapses. These findings suggest that the autistic patient NMDAR-Abs do not play a direct role in the etiology of ASD and that other autoantibodies directed against neuronal targets should be investigated.
Collapse
Affiliation(s)
- Hélène Gréa
- University of Bordeaux, Interdisciplinary Institute for Neuroscience (HNS), Mixed Research Unit (UMR) 5297, Bordeaux, France; National Center for Scientific Research (CNRS), IINS UMR 5297, Bordeaux, France (Equal contribution)
| | - Isabelle Scheid
- University Paris Est Créteil, Psychiatry department, University Hospital Henri Mondor, Public Hospitals of Paris (AP-HP), University Hospital Department of Personalized Neurology and Psychiatry (DHU PePSY), France; Translational Psychiatry Laboratory, National Institute of Health and Medical Research (Inserm) U955, France; FondaMental Foundation, France
| | - Alexandru Gaman
- University Paris Est Créteil, Psychiatry department, University Hospital Henri Mondor, Public Hospitals of Paris (AP-HP), University Hospital Department of Personalized Neurology and Psychiatry (DHU PePSY), France; Translational Psychiatry Laboratory, National Institute of Health and Medical Research (Inserm) U955, France; FondaMental Foundation, France
| | - Véronique Rogemond
- Institut NeuroMyoGene Inserm U1217/CNRS UMR 5310, Lyon, France; Lyon Civil Hospitals, Neurological Hospital, Bron, France; University of Lyon - University Claude Bernard Lyon 1, Lyon, France
| | - Sandy Gillet
- Institut NeuroMyoGene Inserm U1217/CNRS UMR 5310, Lyon, France; Lyon Civil Hospitals, Neurological Hospital, Bron, France; University of Lyon - University Claude Bernard Lyon 1, Lyon, France
| | - Jérôme Honnorat
- Institut NeuroMyoGene Inserm U1217/CNRS UMR 5310, Lyon, France; Lyon Civil Hospitals, Neurological Hospital, Bron, France; University of Lyon - University Claude Bernard Lyon 1, Lyon, France
| | - Federico Bolognani
- Roche Institute, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | - Christian Czech
- Roche Institute, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | - Céline Bouquet
- Roche Institute, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | | | - Manuel Bouvard
- Aquitane Autism Resource Center, Charles Perrens Hospital, Bordeaux
| | | | - Laurent Groc
- University of Bordeaux, Interdisciplinary Institute for Neuroscience (IINS), Mixed Research Unit (UMR) 5297, Bordeaux, France; National Center for Scientific Research (CNRS), IINS UMR 5297, Bordeaux, France; FondaMental Foundation, France (Equal seniority)
| | - Marion Leboyer
- University Paris Est Créteil, Psychiatry department, University Hospital Henri Mondor, Public Hospitals of Paris (AP-HP), University Hospital Department of Personalized Neurology and Psychiatry (DHU PePSY), France; Translational Psychiatry Laboratory, National Institute of Health and Medical Research (Inserm) U955, France; FondaMental Foundation, France
| |
Collapse
|
11
|
Bucci MP, Goulème N, Stordeur C, Acquaviva E, Scheid I, Lefebvre A, Gerard C, Peyre H, Delorme R. Discriminant validity of spatial and temporal postural index in children with neurodevelopmental disorders. Int J Dev Neurosci 2017; 61:51-57. [DOI: 10.1016/j.ijdevneu.2017.06.010] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2017] [Revised: 06/30/2017] [Accepted: 06/30/2017] [Indexed: 11/28/2022] Open
Affiliation(s)
- Maria Pia Bucci
- UMR 1141 Inserm – Paris Diderot University, Robert Debré HospitalParisFrance
| | - Nathalie Goulème
- UMR 1141 Inserm – Paris Diderot University, Robert Debré HospitalParisFrance
- Lyon Neuroscience Research Center (Inserm U1028 CNRS UMR5292), LyonFrance & Department of Audiology and Otoneurological EvaluationCivil Hospitals of LyonLyonFrance
| | - Coline Stordeur
- Child and Adolescent Psychiatry DepartmentRobert Debré HospitalParisFrance
| | - Eric Acquaviva
- Child and Adolescent Psychiatry DepartmentRobert Debré HospitalParisFrance
| | - Isabelle Scheid
- Child and Adolescent Psychiatry DepartmentRobert Debré HospitalParisFrance
- High Functioning Autism Expert Centre, Fondamental FoundationParisFrance
| | - Aline Lefebvre
- Child and Adolescent Psychiatry DepartmentRobert Debré HospitalParisFrance
| | | | - Hugo Peyre
- Child and Adolescent Psychiatry DepartmentRobert Debré HospitalParisFrance
- Paris Diderot UniversityParis 7France
- High Functioning Autism Expert Centre, Fondamental FoundationParisFrance
| | - Richard Delorme
- Child and Adolescent Psychiatry DepartmentRobert Debré HospitalParisFrance
- Paris Diderot UniversityParis 7France
- High Functioning Autism Expert Centre, Fondamental FoundationParisFrance
| |
Collapse
|
12
|
Gaman A, Godin O, Scheid I, Monnet D, Murzi E, Martinez Teruel A, Amsellem F, Laouamri H, Souyris K, Houneou J, Infor T, Delorme R, Leboyer M. Psychiatric Co-morbidities in a French Cohort of Adults with High-functioning Autism (HFA). Eur Psychiatry 2017. [DOI: 10.1016/j.eurpsy.2017.01.1960] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
Background and rationalePsychiatric comorbidities are shown to be very prevalent in patients diagnosed with Autism Spectrum Disorder (ASD), up high to 53% for mood, 50% anxiety and 43% for ADHD disorders in an European cohort of adults with HFA. Using a new approach, our study proposes to explore aspects of comorbidities in the largest French cohort of HFA adults (C0733/InfoR) by implying qualitative and quantitative clinical tools.AimsTo explore: (1) the prevalence rates of psychiatric comorbidities; (2) the interplay between comorbidities and the ASD symptoms.MethodsDiagnosis was made according to DSM 5 criteria. Dimensional evaluation used Social Responsiveness Scale (SRS), Systemizing Quotient (SQ) and Empathy Quotient (EQ). We used T-test, Mann–Whitney test and linear regression models.ResultsWe included 103 patients (mean age 29.3, sex ratio M/F: 3.4:1). Lifetime prevalence rates of 53.5% for depressive disorder 73.5% for anxiety disorders and 37.5% for ADHD were found. Subjects with psychotic co-morbid symptoms had a more severe social deficit (SRS score 66.2 vs 77.9 P < 0.05); patients with ADHD, lower cognition (mean IQ total 107.7 vs 99.0 P < 0.05). SQs (P < 0.05) were significantly higher in patients with co-morbid psychosis, dysthymia, suicide attempts, and depressive disorders and directly correlated with age (β = 0.35, P < 0.05). SQ and EQ were inversely correlated.DiscussionThe results reproduce the high prevalence of comorbidities in other studies and explore its association with social functioning and cognition. Identification of associated psychiatric conditions in subjects with HFA is therefore a crucial clinical issue potentially guiding the treatment.Disclosure of interestThe authors have not supplied their declaration of competing interest.
Collapse
|
13
|
Ioannou C, Zein ME, Wyart V, Scheid I, Amsellem F, Delorme R, Chevallier C, Grèzes J. Shared mechanism for emotion processing in adolescents with and without autism. Sci Rep 2017; 7:42696. [PMID: 28218248 PMCID: PMC5317002 DOI: 10.1038/srep42696] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2016] [Accepted: 01/05/2017] [Indexed: 12/28/2022] Open
Abstract
Although, the quest to understand emotional processing in individuals with Autism Spectrum Disorders (ASD) has led to an impressive number of studies, the picture that emerges from this research remains inconsistent. Some studies find that Typically Developing (TD) individuals outperform those with ASD in emotion recognition tasks, others find no such difference. In this paper, we move beyond focusing on potential group differences in behaviour to answer what we believe is a more pressing question: do individuals with ASD use the same mechanisms to process emotional cues? To this end, we rely on model-based analyses of participants’ accuracy during an emotion categorisation task in which displays of anger and fear are paired with direct vs. averted gaze. Behavioural data of 20 ASD and 20 TD adolescents revealed that the ASD group displayed lower overall performance. Yet, gaze direction had a similar impact on emotion categorisation in both groups, i.e. improved accuracy for salient combinations (anger-direct, fear-averted). Critically, computational modelling of participants’ behaviour reveals that the same mechanism, i.e. increased perceptual sensitivity, underlies the contextual impact of gaze in both groups. We discuss the specific experimental conditions that may favour emotion processing and the automatic integration of contextual information in ASD.
Collapse
Affiliation(s)
- Christina Ioannou
- Laboratoire de Neurosciences Cognitives, Inserm unit 960, Département d'Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, Paris, 75005, France
| | - Marwa El Zein
- Laboratoire de Neurosciences Cognitives, Inserm unit 960, Département d'Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, Paris, 75005, France
| | - Valentin Wyart
- Laboratoire de Neurosciences Cognitives, Inserm unit 960, Département d'Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, Paris, 75005, France
| | - Isabelle Scheid
- Centre Expert Asperger, Fondation Fondamental, Paris, 75019, France.,Service de Psychiatrie de l'Enfant et de l'Adolescent, Hôpital Universitaire Robert Debré, Paris, 75019, France
| | - Frédérique Amsellem
- Service de Psychiatrie de l'Enfant et de l'Adolescent, Hôpital Universitaire Robert Debré, Paris, 75019, France.,Génétique Humaine et Fonction Cognitive, Institut Pasteur, Paris, 75015, France
| | - Richard Delorme
- Service de Psychiatrie de l'Enfant et de l'Adolescent, Hôpital Universitaire Robert Debré, Paris, 75019, France.,Génétique Humaine et Fonction Cognitive, Institut Pasteur, Paris, 75015, France
| | - Coralie Chevallier
- Laboratoire de Neurosciences Cognitives, Inserm unit 960, Département d'Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, Paris, 75005, France
| | - Julie Grèzes
- Laboratoire de Neurosciences Cognitives, Inserm unit 960, Département d'Etudes Cognitives, Ecole Normale Supérieure, PSL Research University, Paris, 75005, France
| |
Collapse
|
14
|
Beggiato A, Peyre H, Maruani A, Scheid I, Rastam M, Amsellem F, Gillberg CI, Leboyer M, Bourgeron T, Gillberg C, Delorme R. Gender differences in autism spectrum disorders: Divergence among specific core symptoms. Autism Res 2016; 10:680-689. [DOI: 10.1002/aur.1715] [Citation(s) in RCA: 93] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2015] [Revised: 09/12/2016] [Accepted: 09/26/2016] [Indexed: 11/08/2022]
Affiliation(s)
- Anita Beggiato
- Department of Child and Adolescent Psychiatry; Robert Debré Hospital, APHP; Paris France
- Human Genetics and Cognitive Functions; Institut Pasteur; Paris France
| | - Hugo Peyre
- Department of Child and Adolescent Psychiatry; Robert Debré Hospital, APHP; Paris France
| | - Anna Maruani
- Department of Child and Adolescent Psychiatry; Robert Debré Hospital, APHP; Paris France
- Human Genetics and Cognitive Functions; Institut Pasteur; Paris France
| | - Isabelle Scheid
- Department of Child and Adolescent Psychiatry; Robert Debré Hospital, APHP; Paris France
- Human Genetics and Cognitive Functions; Institut Pasteur; Paris France
- Fondation FondaMental, French National Science Foundation
| | - Maria Rastam
- Department of Clinical Sciences; Lund University; Lund Sweden
| | - Frederique Amsellem
- Department of Child and Adolescent Psychiatry; Robert Debré Hospital, APHP; Paris France
- Human Genetics and Cognitive Functions; Institut Pasteur; Paris France
| | | | - Marion Leboyer
- Fondation FondaMental, French National Science Foundation
- INSERM U955; Paris France
- Department of Adult Psychiatry; H Mondor & A Chenevier Hospitals, APHP; Paris France
| | - Thomas Bourgeron
- Human Genetics and Cognitive Functions; Institut Pasteur; Paris France
- University Denis Diderot Paris 7; Paris France
| | - Christopher Gillberg
- Gillberg neuropsychiatry Centre; Gothenburg University; Göteborg Sweden
- Institute of Child Health, University College London; London UK
| | - Richard Delorme
- Department of Child and Adolescent Psychiatry; Robert Debré Hospital, APHP; Paris France
- Human Genetics and Cognitive Functions; Institut Pasteur; Paris France
- Fondation FondaMental, French National Science Foundation
- University Denis Diderot Paris 7; Paris France
| |
Collapse
|
15
|
Scheid I, Maruani A, Huguet G, Leblond CS, Nygren G, Anckarsäter H, Beggiato A, Rastam M, Amsellem F, Gillberg IC, Elmaleh M, Leboyer M, Gillberg C, Betancur C, Coleman M, Hama H, Cook EH, Bourgeron T, Delorme R. Heterozygous FA2H mutations in autism spectrum disorders. BMC Med Genet 2013; 14:124. [PMID: 24299421 PMCID: PMC4219428 DOI: 10.1186/1471-2350-14-124] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/17/2013] [Accepted: 11/18/2013] [Indexed: 11/16/2022]
Abstract
BACKGROUND Widespread abnormalities in white matter development are frequently reported in cases of autism spectrum disorders (ASD) and could be involved in the disconnectivity suggested in these disorders. Homozygous mutations in the gene coding for fatty-acid 2-hydroxylase (FA2H), an enzyme involved in myelin synthesis, are associated with complex leukodystrophies, but little is known about the functional impact of heterozygous FA2H mutations. We hypothesized that rare deleterious heterozygous mutations of FA2H might constitute risk factors for ASD. METHODS We searched deleterious mutations affecting FA2H, by genotyping 1256 independent patients with ASD genotyped using Genome Wide SNP arrays, and also by sequencing in independent set of 186 subjects with ASD and 353 controls. We then explored the impact of the identified mutations by measuring FA2H enzymatic activity and expression, in transfected COS7 cells. RESULTS One heterozygous deletion within 16q22.3-q23.1 including FA2H was observed in two siblings who share symptoms of autism and severe cognitive impairment, axial T2-FLAIR weighted MRI posterior periventricular white matter lesions. Also, two rare non-synonymous mutations (R113W and R113Q) were reported. Although predictive models suggested that R113W should be a deleterious, we did not find that FA2H activity was affected by expression of the R113W mutation in cultured COS cells. CONCLUSIONS While our results do not support a major role for FA2H coding variants in ASD, a screening of other genes related to myelin synthesis would allow us to better understand the role of non-neuronal elements in ASD susceptibility.
Collapse
Affiliation(s)
- Isabelle Scheid
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA2182, Paris, France
- APHP, Robert Debré Hospital, Child and Adolescent Psychiatry, Paris, France
| | - Anna Maruani
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA2182, Paris, France
- APHP, Robert Debré Hospital, Child and Adolescent Psychiatry, Paris, France
| | - Guillaume Huguet
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA2182, Paris, France
| | - Claire S Leblond
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA2182, Paris, France
| | - Gudrun Nygren
- Gillberg Neuropsychiatry Centre, Gothenburg University, Göteborg, Sweden
| | | | - Anita Beggiato
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA2182, Paris, France
- APHP, Robert Debré Hospital, Child and Adolescent Psychiatry, Paris, France
- Fondation FondaMental, French National Science Foundation, Creteil, France
| | - Maria Rastam
- Department of Clinical Sciences, Lund University, Lund, Sweden
| | - Fréderique Amsellem
- APHP, Robert Debré Hospital, Child and Adolescent Psychiatry, Paris, France
- INSERM U955, Psychiatry Genetics, Créteil, France
| | - I Carina Gillberg
- Gillberg Neuropsychiatry Centre, Gothenburg University, Göteborg, Sweden
| | - Monique Elmaleh
- APHP, Robert Debré Hospital Paediatric Imaging, Paris, France
| | - Marion Leboyer
- Fondation FondaMental, French National Science Foundation, Creteil, France
- INSERM U955, Psychiatry Genetics, Créteil, France
| | - Christopher Gillberg
- Gillberg Neuropsychiatry Centre, Gothenburg University, Göteborg, Sweden
- Institute of Child Health, University College London, London, UK
| | - Catalina Betancur
- INSERM U952, Paris, France
- CNRS UMR7224, Paris, France
- UPMC Univ Paris 06, Paris, France
| | - Mary Coleman
- Foundation for Autism Research, Sarasota, Florida 34235-7117, USA
| | - Hiroko Hama
- Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina, USA
| | - Edwin H Cook
- Institute for Juvenile Research, Department of Psychiatry, University of Illinois at Chicago, Illinois, USA
| | - Thomas Bourgeron
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA2182, Paris, France
- University Denis Diderot Paris 7, 75013 Paris, France
| | - Richard Delorme
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA2182, Paris, France
- APHP, Robert Debré Hospital, Child and Adolescent Psychiatry, Paris, France
| |
Collapse
|
16
|
Chaste P, Clement N, Botros HG, Guillaume JL, Konyukh M, Pagan C, Scheid I, Nygren G, Anckarsäter H, Rastam M, Ståhlberg O, Gillberg IC, Melke J, Delorme R, Leblond C, Toro R, Huguet G, Fauchereau F, Durand C, Boudarene L, Serrano E, Lemière N, Launay JM, Leboyer M, Jockers R, Gillberg C, Bourgeron T. Genetic variations of the melatonin pathway in patients with attention-deficit and hyperactivity disorders. J Pineal Res 2011; 51:394-9. [PMID: 21615493 DOI: 10.1111/j.1600-079x.2011.00902.x] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Melatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration in melatonin signaling has been reported in a broad range of diseases, but little is known about the genetic variability of this pathway in humans. Here, we sequenced all the genes of the melatonin pathway -AA-NAT, ASMT, MTNR1A, MTNR1B and GPR50 - in 321 individuals from Sweden including 101 patients with attention-deficit/hyperactivity disorder (ADHD) and 220 controls from the general population. We could find several damaging mutations in patients with ADHD, but no significant enrichment compared with the general population. Among these variations, we found a splice site mutation in ASMT (IVS5+2T>C) and one stop mutation in MTNR1A (Y170X) - detected exclusively in patients with ADHD - for which biochemical analyses indicated that they abolish the activity of ASMT and MTNR1A. These genetic and functional results represent the first comprehensive ascertainment of melatonin signaling deficiency in ADHD.
Collapse
Affiliation(s)
- Pauline Chaste
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Chaste P, Clement N, Mercati O, Guillaume JL, Delorme R, Botros HG, Pagan C, Périvier S, Scheid I, Nygren G, Anckarsäter H, Rastam M, Ståhlberg O, Gillberg C, Serrano E, Lemière N, Launay JM, Mouren-Simeoni MC, Leboyer M, Gillberg C, Jockers R, Bourgeron T. Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population. PLoS One 2010; 5:e11495. [PMID: 20657642 PMCID: PMC2904695 DOI: 10.1371/journal.pone.0011495] [Citation(s) in RCA: 51] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2010] [Accepted: 06/09/2010] [Indexed: 11/18/2022] Open
Abstract
Melatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration of the melatonin pathway has been reported in circadian disorders, diabetes and autism spectrum disorders (ASD). However, very little is known about the genetic variability of melatonin receptors in humans. Here, we sequenced the melatonin receptor MTNR1A and MTNR1B, genes coding for MT1 and MT2 receptors, respectively, in a large panel of 941 individuals including 295 patients with ASD, 362 controls and 284 individuals from different ethnic backgrounds. We also sequenced GPR50, coding for the orphan melatonin-related receptor GPR50 in patients and controls. We identified six non-synonymous mutations for MTNR1A and ten for MTNR1B. The majority of these variations altered receptor function. Particularly interesting mutants are MT1-I49N, which is devoid of any melatonin binding and cell surface expression, and MT1-G166E and MT1-I212T, which showed severely impaired cell surface expression. Of note, several mutants possessed pathway-selective signaling properties, some preferentially inhibiting the adenylyl cyclase pathway, others preferentially activating the MAPK pathway. The prevalence of these deleterious mutations in cases and controls indicates that they do not represent major risk factor for ASD (MTNR1A case 3.6% vs controls 4.4%; MTNR1B case 4.7% vs 3% controls). Concerning GPR50, we detected a significant association between ASD and two variations, Δ502–505 and T532A, in affected males, but it did not hold up after Bonferonni correction for multiple testing. Our results represent the first functional ascertainment of melatonin receptors in humans and constitute a basis for future structure-function studies and for interpreting genetic data on the melatonin pathway in patients.
Collapse
Affiliation(s)
- Pauline Chaste
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA 2182 “Genes, synapses et cognition”, Institut Pasteur, Paris, France
| | - Nathalie Clement
- Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France
- INSERM U1016, Paris, France
| | - Oriane Mercati
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA 2182 “Genes, synapses et cognition”, Institut Pasteur, Paris, France
| | - Jean-Luc Guillaume
- Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France
- INSERM U1016, Paris, France
| | - Richard Delorme
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA 2182 “Genes, synapses et cognition”, Institut Pasteur, Paris, France
- Service de Psychopathologie de l′Enfant et de l′Adolescent, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Hany Goubran Botros
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA 2182 “Genes, synapses et cognition”, Institut Pasteur, Paris, France
| | - Cécile Pagan
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA 2182 “Genes, synapses et cognition”, Institut Pasteur, Paris, France
| | - Samuel Périvier
- Service de Psychopathologie de l′Enfant et de l′Adolescent, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Isabelle Scheid
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA 2182 “Genes, synapses et cognition”, Institut Pasteur, Paris, France
| | - Gudrun Nygren
- Department of Child and Adolescent Psychiatry, Göteborg University, Göteborg, Sweden
| | - Henrik Anckarsäter
- Department of Child and Adolescent Psychiatry, Göteborg University, Göteborg, Sweden
- Institute of Clinical Sciences, Lund University, Malmö, Sweden
| | - Maria Rastam
- Department of Clinical Sciences in Lund, Lund University, Lund, Sweden
| | - Ola Ståhlberg
- Department of Child and Adolescent Psychiatry, Göteborg University, Göteborg, Sweden
| | - Carina Gillberg
- Department of Child and Adolescent Psychiatry, Göteborg University, Göteborg, Sweden
| | - Emilie Serrano
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA 2182 “Genes, synapses et cognition”, Institut Pasteur, Paris, France
| | - Nathalie Lemière
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA 2182 “Genes, synapses et cognition”, Institut Pasteur, Paris, France
| | - Jean Marie Launay
- Service de Biochimie, IFR 139, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris EA 3621, Paris, France
| | - Marie Christine Mouren-Simeoni
- Service de Psychopathologie de l′Enfant et de l′Adolescent, Hôpital Robert Debré, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Marion Leboyer
- INSERM U955, Institut Mondor de Recherche Biomédicale, Université Paris XII, Créteil, France
- Foundation Fondamental, Créteil, France
| | - Christopher Gillberg
- Department of Child and Adolescent Psychiatry, Göteborg University, Göteborg, Sweden
- Saint George's Hospital Medical School, London, United Kingdom
| | - Ralf Jockers
- Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France
- INSERM U1016, Paris, France
- * E-mail:
| | - Thomas Bourgeron
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France
- CNRS URA 2182 “Genes, synapses et cognition”, Institut Pasteur, Paris, France
- Foundation Fondamental, Créteil, France
- University Denis Diderot Paris 7, Paris, France
| |
Collapse
|
18
|
Delorme R, Betancur C, Scheid I, Anckarsäter H, Chaste P, Jamain S, Schuroff F, Nygren G, Herbrecht E, Dumaine A, Mouren MC, Råstam M, Leboyer M, Gillberg C, Bourgeron T. Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls. BMC Med Genet 2010; 11:108. [PMID: 20602773 PMCID: PMC2919462 DOI: 10.1186/1471-2350-11-108] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/03/2009] [Accepted: 07/05/2010] [Indexed: 01/06/2023]
Abstract
Background The gene encoding carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase (NOS1AP) is located on chromosome 1q23.3, a candidate region for schizophrenia, autism spectrum disorders (ASD) and obsessive-compulsive disorder (OCD). Previous genetic and functional studies explored the role of NOS1AP in these psychiatric conditions, but only a limited number explored the sequence variability of NOS1AP. Methods We analyzed the coding sequence of NOS1AP in a large population (n = 280), including patients with schizophrenia (n = 72), ASD (n = 81) or OCD (n = 34), and in healthy volunteers controlled for the absence of personal or familial history of psychiatric disorders (n = 93). Results Two non-synonymous variations, V37I and D423N were identified in two families, one with two siblings with OCD and the other with two brothers with ASD. These rare variations apparently segregate with the presence of psychiatric conditions. Conclusions Coding variations of NOS1AP are relatively rare in patients and controls. Nevertheless, we report the first non-synonymous variations within the human NOS1AP gene that warrant further genetic and functional investigations to ascertain their roles in the susceptibility to psychiatric disorders.
Collapse
Affiliation(s)
- Richard Delorme
- Human Genetics and Cognitive Functions, Institut Pasteur, Paris, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Delorme R, Chaste P, Scheid I, Cortese S, Mouren MC. Using videotaped vignettes to improve the teaching quality in child and adolescent psychiatry. Med Teach 2010; 32:703-704. [PMID: 20695031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
|